Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

17.36
-0.0750-0.43%
Volume:162.06K
Turnover:2.84M
Market Cap:773.37M
PE:-10.53
High:17.88
Open:17.47
Low:17.26
Close:17.43
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:26.52M
Volume Ratio:0.31
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.02
PE(LYR):-9.59

Loading ...

Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1

Reuters
·
May 27

Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58

Reuters
·
May 27

Beta Bionics Stockholders Approve Directors and Auditor Ratification

TIPRANKS
·
May 23

Beta Bionics shareholders elect two directors at annual meeting

Reuters
·
May 23

Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

TIPRANKS
·
May 22

Piper Sandler Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)

TIPRANKS
·
May 22

Travis Steed Reaffirms Hold on Beta Bionics, Lifts Price Target to $13 on Accelerated Mint Launch but Sees Balanced Risk‑Reward

TIPRANKS
·
May 22

Beta Bionics Targets 2027 Commercial Launch of Mint Pump

TIPRANKS
·
May 22

Beta Bionics Inc - Expects Manufacturing Capacity to Meet Demand at Mint Launch

THOMSON REUTERS
·
May 22

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development

GlobeNewswire
·
May 22

Beta Bionics Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 19

Beta Bionics Inc : Bofa Global Research Cuts Price Objective to $11 From $23

THOMSON REUTERS
·
May 18

BofA Adjusts Price Target on Beta Bionics to $11 From $23

MT Newswires Live
·
May 18

Beta Bionics price target lowered to $11 from $23 at BofA

TIPRANKS
·
May 18

Beta Bionics to present at Bank of America Securities Health Care Conference

Reuters
·
Apr 28

Beta Bionics Earnings Call Highlights Growth And Risks

TIPRANKS
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Danaher (DHR) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Apr 22

Beta Bionics Is Maintained at Buy by Stifel

Dow Jones
·
Apr 22

Beta Bionics price target lowered to $20 from $32 at Piper Sandler

TIPRANKS
·
Apr 22

Piper Sandler Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Apr 22